National Blood Authority s1

NATIONAL BLOOD AUTHORITY

Agency Resources and Planned Performance

National Blood Authority Health and Ageing Portfolio Agency

3 NBA NBA - Agency Budget Statements – Agency Overview and Resources

Section 1: Agency Overview and Resources

1.1 Strategic Direction Statement The Australian Government, through the National Blood Authority (NBA), aims to ensure that Australia’s blood supply is secure and well managed. The NBA is an independent statutory agency, established by the Australian Government and state and territory governments, to coordinate policy, governance, funding and management of the blood banking and plasma product sector in Australia. The role and functions of the NBA are set out in the National Blood Authority Act 2003. The NBA is prescribed as an agency under the Financial Management and Accountability Act 1997. 1.2 Agency Resources Table 1.2.1 shows the total resources from all origins. The table summarises how resources will be applied by outcome and by Departmental classifications.

Table 1.2.1: NBA Resource Statement – Budget Estimates for 2013-14 as at Budget May 2013 Estimate Proposed Total Estimated of prior year at Budget estimate available amounts appropriation available in 2013-14 2013-14 2013-14 2012-13 $'000 $'000 $'000 $'000 Ordinary annual services1 Departmental appropriation Prior year departmental appropriation and opening reserves - - Departmental appropriation2 6,234 6,234 7,298 s31 Relevant agency receipts - - - - Total - 6,234 6,234 7,298 Administered resources1 Outcome 1 - 7,544 7,544 8,358 Total - 7,544 7,544 8,358 Total ordinary annual services - 13,778 13,778 15,656 Other services - Bill 23 Departmental non-operating Equity injections - - - - Previous years' programs - - - - Total - - - - Total other services - - - - Total available annual appropriations - 13,778 13,778 15,656 Total appropriations excluding Special Accounts - 13,778 13,778 15,656 Special Accounts Opening balance4 206,974 - 206,974 198,894 Appropriation receipts5 - 13,778 13,778 15,656 Appropriation receipts - other agencies6 - 716,039 716,039 674,348 Non-appropriation receipts to Special Accounts - 435,195 435,195 421,538 Total Special Accounts 206,974 1,165,012 1,371,986 1,310,436 Total resourcing 206,974 1,178,790 1,385,764 1,326,092

Less appropriations drawn from annual or special appropriations above and credited to Special Accounts and/or CAC Act bodies through annual appropriations - (13,778) (13,778) (15,656) Total net resourcing for NBA 206,974 1,165,012 1,371,986 1,310,436

Notes: All figures are GST exclusive 1 Appropriation Bill (No. 1) 2013-14. 2 Includes an amount of $0.115 m in 2013-14 for the Departmental Capital Budget (refer to Table 3.2.5 for further details). For accounting purposes this amount has been designated as ‘contributions by owners’. 3 Appropriation Bill (No. 2) 2013-14. 4 Estimated opening balance for special accounts. For further information on special accounts see Table 3.1.2. 5 Appropriation receipts from NBA annual and special appropriations for 2013-14 included above.

6 Appropriation receipts from the Department of Health and Ageing.

1.3 Budget Measures Budget measures relating to NBA are detailed in Budget Paper No. 2 and are summarised below. Table 1.3.1: NBA Budget Measures Part 1: Measures announced since the 2012-13 MYEFO Progra 2012-13 2013-14 2014-15 2015-16 2016-17 m $'000 $'000 $'000 $'000 $'000 Health program funding – Better targeting National Blood Authority Administered expenses 1.1 - (343) (10,448) (20,894) (29,041) Total expenses - (343) (10,448) (20,894) (29,041) National Blood Authority Administered revenue - (127) (3,866) (7,731) (10,745) Total revenue - (127) (3,866) (7,731) (10,745)

Part 2: MYEFO measures not previously reported in a portfolio statement

Whole of Government Measures Targeted savings - public service efficiencies1 National Blood Authority Departmental expenses 1.1 (23) (36) (85) (98) (96) Total (23) (36) (85) (98) (96)

1 Measure reported includes amounts previously reported in the Health and Ageing 2012-13 Portfolio Additional Estimates Statements (page 25).

Section 2: Outcomes and Planned Performance

2.1 Outcomes and Performance Information Outcome 1 - Access to a secure supply of safe and affordable blood products, including through national supply arrangements and coordination of best practice standards within agreed funding policies under the national blood arrangements

Outcome Strategy The Australian Government aims to ensure that the public has timely access to safe blood and blood products. The NBA, on behalf of the Australian Government and state and territory governments, manages and coordinates national contracts to secure the supply of safe and affordable blood products in Australia in accordance with the National Blood Agreement. The NBA works with governments and stakeholders to implement an efficient, demanddriven blood supply system that is highly responsive to needs and based upon evidence and good clinical practice. The NBA will continue to improve the purchasing and supply arrangements for fresh, fractionated and recombinant products1 through the collaborative implementation of comprehensive risk mitigation strategies. Recognising the growing cost of blood products and the growing evidence of risk associated with unnecessary transfusions, the NBA will undertake a range of activities aimed at improving the clinical usage of blood and blood products. Specifically, the NBA will improve the sustainability and performance of the sector through enhanced data capture and the collaborative and professional analysis of this data. The NBA will also work to facilitate development and publication of evidence-based national guidelines, informed by close engagement with clinicians, to raise awareness of the Health Minister’s stewardship expectations of users of blood and blood products and management of these products.

1 Fractionated products are those derived from human plasma whereas recombinant products are those synthetically derived. 8 NBA NBA - Agency Budget Statements – Agency Overview and Resources

NBA Budgeted Expenses and Resources Table 2.1.1 provides an overview of the total expenses for NBA by Program. Table 2.1.1: Budgeted Expenses and Resources for NBA 2012-13 2013-14 2014-15 2015-16 2016-17 Estimate Budget Forward Forward Forward d year 1 year 2 year 3 actual $'000 $'000 $'000 $'000 $'000 Program 1.1: National blood agreement management Administered expenses Ordinary annual services 8,358 7,544 - - - (Appropriation Bill No. 1) to the National Blood Authority Account (8,358) (7,544) - - - to the National Managed Fund (Blood and Blood Products) Special Account - - - - - Special accounts National Blood Authority 1,203,00 Account 1,077,429 1,127,414 9 1,280,081 1,370,351 National Managed Fund (Blood and Blood Products) Special Account - - - - - Departmental expenses Departmental appropriation1 6,201 6,119 6,085 6,099 6,112 To National Blood Authority Account (6,201) (6,119) (6,085) (6,099) (6,112) Special Account National Blood Authority Account 10,555 9,635 9,624 9,665 9,685 Expenses not requiring appropriation in the budget year2 1,046 761 768 694 671 Operating deficit (surplus) (722) (153) (279) (14) (15) 1,213,12 Total for Program 1.1 1,088,308 1,137,657 1,290,426 1,380,692 2 1,213,12 Total expenses for Outcome 1 1,088,308 1,137,657 1,290,426 1,380,692 2

2012-13 2013-14 Average staffing level (number) 49 53

1 Departmental appropriation combines "Ordinary annual services (Appropriation Bill No 1)" and "Revenue from independent sources (s31)". 2 Expenses not requiring appropriation in the Budget year is made up of depreciation expense, amortisation expense, makegood expense and audit fees.

Program 1.1: National blood agreement management Program Objectives Secure the supply of blood and blood products The NBA works with state and territory governments and suppliers so that requirements for day-to-day product supply and future demand are well managed. In 2013-14, the NBA will continue to work with the Australian Red Cross Blood Service (Blood Service) to progress the Deed of Agreement to provide fresh blood products for Australia. In addition, the NBA will implement the second cycle of the Output Based Funding Model and a range of other operational standards with the Blood Service to further improve the capacity to meet demand. The NBA will undertake new procurement actions for a range of imported plasma and recombinant products2 and the mid-term review of the agreement with the contracted supplier, CSL. Improve risk management and blood sector performance In 2013-14, the NBA will update arrangements for all blood products to ensure that clinical requirements can be met when there is a disruption to normal supply. The NBA will co-ordinate the review of the National Managed Fund (NMF), oversee the financial investment strategies for the NMF funds and assist in the risk assessment of possible strategies to streamline laws relating to transmission of blood borne disease. The NBA will review and update the National Blood Supply Contingency Plan and assess global and local risks to supply. The NBA will undertake a number of initiatives to improve the efficiency and effectiveness of the blood supply network. This includes: providing advice to governments on the recommendations of the comprehensive review of the clinical and administrative management of intravenous immunoglobulin (IVIg); implementing the policy and standards for barcoding in the sector; piloting and transitioning a national inventory management framework to ensure stocks are managed in the most efficient manner; and work with states and territories to implement a national wastage reduction strategy. The NBA will work with states and territories and all suppliers to continue the nationwide implementation of BloodNet, which will allow real time inventory and wastage monitoring. The NBA will develop an interface for direct patient recording of data in the Australian Bleeding Disorders Register. The NBA will implement a comprehensive national data strategy to drive supply chain efficiencies and improve appropriateness of use within the sector. Promote the safe and efficient use of blood and blood products In 2013-14, the NBA will finalise one further clinical practice guideline with NHMRC for patient blood management, continue to develop the two remaining

2 Recombinant products are those synthetically derived. 10 NBA NBA - Agency Budget Statements – Agency Overview and Resources guidelines, and continue development of guidelines for the comprehensive management of haemophilia. The NBA will work collaboratively with stakeholders in the sector to implement the Patient Blood Management Guidelines Implementation Strategy. Program 1.1: Deliverables Qualitative Deliverables for Program 1.1 Secure the supply of blood and blood products

Qualitative Deliverable 2013-14 Reference Point or Target

New Australian Red Cross Blood Service The second cycle of the Output Based contract arrangements are progressed Funding Model, under the Deed of Agreement, is implemented National Service Standards, Payment and Substitution Rules and the National Inventory Management Framework are progressed

Improve risk management and blood sector performance

Review of the clinical and administrative Recommendations of the Review are management of IVIg is progressed implemented in accordance with governments’ decisions

Promote the safe and efficient use of blood and blood products

National data strategy is progressed Data governance arrangements are implemented and available to stakeholders by December 2013 Performance scorecard is implemented February 2014 and reviewed on ongoing basis Quantitative Deliverable for Program 1.1 Promote the safe and efficient use of blood and blood products

2012-13 2013-14 2014-15 2015-16 2016-17 Quantitative Deliverable Revised Budget Forward Forward Forward Budget Target Year 1 Year 2 Year 3

Number of clinical practice guidelines submitted for 2 1 2 2 2 NHMRC consideration

Program 1.1: Key Performance Indicators Qualitative Key Performance Indicators for Program 1.1 Secure the supply of blood and blood products

Qualitative Indicator 2013-14 Reference Point or Target

NBA funding jurisdictions are satisfied with Satisfaction is assessed through survey of planning, management and coordination of Jurisdictional Blood Committee members NBA activities

Promote the safe and efficient use of blood and blood products

Qualitative Indicator 2013-14 Reference Point or Target

Effective consultation with clinicians on Satisfaction is assessed through surveys of options for the development of a all relevant stakeholders comprehensive national patient blood management program Quantitative Key Performance Indicators for Program 1.1 Secure the supply of blood and blood products

2012-13 2013-14 2014-15 2015-16 2016-17 Quantitative Revised Budget Forward Forward Forward Indicator Budget Target Year 1 Year 2 Year 3

Variance between actual and NBA estimated demand for <5% <5% <5% <5% <5% supply of products

Improve risk management and blood sector performance

2012-13 2013-14 2014-15 2015-16 2016-17 Quantitative Revised Budget Forward Forward Forward Indicator Budget Target Year 1 Year 2 Year 3

Percentage of hospitals using 65% 90% 90% 90% 95% BloodNet3

3 These figures have increased from those published in the 2012-13 Portfolio Budget Statements to reflect the rapid uptake of BloodNet in hospitals. 12 NBA NBA - Agency Budget Statements – Agency Overview and Resources

Section 3: Explanatory Tables and Budgeted Financial Statements

Section 3 presents explanatory tables and budgeted financial statements which provide a comprehensive snapshot of agency finances for the 2013-14 Budget year. It explains how budget plans are incorporated into the financial statements and provides further details of the reconciliation between appropriations and program expenses, movements in administered funds, special accounts and government Indigenous expenditure. 3.1 Explanatory Tables 3.1.1 Movement of administered funds between years Section 3.1.1 is not applicable to the NBA. 3.1.2 Special Accounts Table 3.1.2: Estimates of Special Account Flows and Balances Appropriatio Opening n Other Payments Closing balance receipts receipts balance 2013-14 2013-14 2013-14 2013-14 2013-14 2012-13 2012-13 2012-13 2012-13 2012-13 Outcome $'000 $'000 $'000 $'000 $'000 199,40 1,134,82 1,128,01 National Blood Authority 1 7 7,544 6 6 213,761 1,078,94 1,079,00 Account1 (A) 191,106 8,358 3 0 199,407 National Blood Authority 1 7,260 6,234 3,516 9,582 7,428 Account1 (D) 7,481 7,298 4,358 11,877 7,260 National Managed Fund 1 (Blood and Blood Products) 307 - 12,892 5,316 7,883 Special Account2, 3 (A) 307 - 12,585 12,585 307

Total Special Accounts 1,151,23 1,142,91 201314 Estimate 206,974 13,778 4 4 229,072 Total Special Accounts 2012-13 1,095,88 1,103,46 estimate actual 198,894 15,656 6 2 206,974

Other Trust Money - s20 FMA has been abolished. D = Departmental; A = Administered. 1 National Blood Authority Act 2003 - s21 FMA Act. 2 s20 FMA Act. 3 In 2010-11, the NBA was granted investment powers for the National Managed Fund Special Account. Payments represent the purchase of investments. 3.1.3 Australian Government Indigenous Expenditure The 2013-14 Australian Government Indigenous Expenditure (AGIE) statement is not applicable because NBA has no specific Indigenous expenses.

3.2 Budgeted Financial Statements 3.2.1 Differences in agency resourcing and financial statements Section 3.2.1 is not applicable to the NBA. 3.2.2 Analysis of budgeted financial statements An analysis of the NBA’s budgeted financial statements for 2013 -14 is provided below. Departmental Resources Comprehensive Income Statement This statement provides a picture of the expected financial results for the National Blood Authority by identifying accrual expenses and revenues showing the net cost of services. NBA operational costs are funded jointly by the Australian, State and Territory Governments on a 63%:37% basis through annual contributions. All NBA receipts and payments are accounted through special accounts. The NBA is expecting a break even position for the budget year and all forward years. The income statement deficit in the budget year and forward years is as a result of the Government’s decision to no longer fund for depreciation via an operating appropriation. Balance Sheet Special account accumulated funds are held within the Official Public Account and included as Receivables in the Balance Sheet. The NBA always maintains sufficient accumulated funds to cover employee entitlements and other liabilities. The value of intangible assets will fall over 2012-13 and 2013-14 reflecting the use and amortisation of the integrated data management system before increasing again in the forward years due to replacement systems being developed. New fit- out of the NBA office is budgeted in 2013-14. Other non-financial assets and liabilities will remain broadly stable over the period. Administered Resources Schedule of Budgeted Income and Expenses Administered on Behalf of Government The NBA administered accounts include contributions from all states and territories and the Australian Government for the supply of blood and blood related products for 2012-13.Each year the Standing Committee on Health approves an Annual National Supply Plan and Budget which is formulated by the NBA from demand estimates provided by the states and territories. The 2012-13 Budget for the supply of blood and blood products has increased by $60.6 million from 2011-12 reflecting increased demand and price rises. 14 NBA NBA - Agency Budget Statements – Agency Overview and Resources

Schedule of Budgeted Assets and Liabilities Administered on Behalf of Government The schedule of budgeted assets and liabilities administered on behalf of Government illustrates normal movements in non-financial assets and liabilities. The balance of Receivables represents GST payments made to suppliers which are recoverable from the Australian Taxation Office. Other non-financial assets represent a prepayment to the Australian Red Cross Blood Service under the Output Based Funding Model agreement. During 2010-11, the NBA was granted investment powers for the National Managed Fund special account. The increase in Investments over the forward years represents annual contributions received as well as re-investment of interest income.

3.2.3 Budgeted financial statements tables Table 3.2.1: Comprehensive income statement (showing net cost of services) (for the period ended 30 June) Estimated Budget Forward Forward Forward actual estimate estimate estimate estimate 2012-13 2013-14 2014-15 2015-16 2016-17 $'000 $'000 $'000 $'000 $'000 EXPENSES Employee benefits 6,294 6,013 6,063 6,521 6,575 Supplier expenses 3,654 3,584 3,397 3,245 3,210 Depreciation and amortisation 931 646 653 579 556 Total expenses 10,879 10,243 10,113 10,345 10,341 LESS: OWN-SOURCE INCOME Revenue Other revenue 4,354 3,516 3,539 3,566 3,573 Total revenue 4,354 3,516 3,539 3,566 3,573 Gains Other 115 115 115 115 115 Total gains 115 115 115 115 115 Total own-source income 4,469 3,631 3,654 3,681 3,688 Net cost of (contribution by) services 6,410 6,612 6,459 6,664 6,653 Revenue from Government 6,201 6,119 6,085 6,099 6,112 Surplus (Deficit) (209) (493) (374) (565) (541) Surplus (Deficit) attributable to the Australian Government (209) (493) (374) (565) (541) OTHER COMPREHENSIVE INCOME Changes in asset revaluation reserves - - - - - Total other comprehensive income - - - - - Total comprehensive income attributable to the Australian Government (209) (493) (374) (565) (541)

Note: Reconciliation of comprehensive income attributable to the agency 2012-13 2013-14 2014-15 2015-16 2016-17 $'000 $'000 $'000 $'000 $'000 Total comprehensive income (loss) attributable to the Australian Government (209) (493) (374) (565) (541) plus non-appropriated expense depreciation and amortisation expenses 931 646 653 579 556 Total comprehensive income (loss) attributable to the agency 722 153 279 14 15

Table 3.2.2: Budgeted Departmental Balance Sheet (as at 30 June) Estimated Budget Forward Forward Forward actual estimate estimate estimate estimate 2012-13 2013-14 2014-15 2015-16 2016-17 $'000 $'000 $'000 $'000 $'000 ASSETS Financial assets Cash and cash equivalents 30 30 30 30 30 Receivables 7,769 7,936 7,861 7,781 7,760 Total financial assets 7,799 7,966 7,891 7,811 7,790 Non-financial assets Land and buildings 990 890 790 690 590 Property, plant and equipment 548 373 291 279 169 Intangibles 462 274 879 511 266 Other 87 87 87 87 87 Total non-financial assets 2,087 1,624 2,047 1,567 1,112 Total assets 9,886 9,590 9,938 9,378 8,902 LIABILITIES Payables Suppliers 571 572 572 472 472 Other payables - - - - - Total payables 571 572 572 472 472 Provisions Employees 1,066 1,147 1,188 1,229 1,229 Other provisions - - - - - Total provisions 1,066 1,147 1,188 1,229 1,229 Total liabilities 1,637 1,719 1,760 1,701 1,701 Net Assets 8,249 7,871 8,178 7,677 7,201 EQUITY Contributed equity 2,463 2,578 3,259 3,323 3,388 Reserves 206 206 206 206 206 Retained surpluses or accumulated deficits 5,580 5,087 4,713 4,148 3,607 Total equity 8,249 7,871 8,178 7,677 7,201

Table 3.2.3: Departmental statement of changes in equity — summary of movement (Budget year 2013-14) Retained Asset Other Contribute Total Earnings revaluatio Reserves d Equity n equity/ $'000 reserve $'000 capital $'000 $'000 $'000 Opening balance as at 1 July 2013 Balance carried forward from previous period 5,580 206 - 2,463 8,249 Surplus (deficit) for the period (493) - - - (493) Appropriation (equity injection) - - - - - Capital budget - Bill 1 (DCB) - - - 115 115 Estimated closing balance as at 30 June 2014 5,087 206 - 2,578 7,871

DCB = Departmental Capital Budget.

Table 3.2.4: Budgeted Departmental statement of cash flows (for the period ended 30 June) Estimated Budget Forward Forward Forward actual estimate estimate estimate estimate 2012-13 2013-14 2014-15 2015-16 2016-17 $'000 $'000 $'000 $'000 $'000 OPERATING ACTIVITIES Cash received Appropriations 6,201 6,119 6,085 6,099 6,112 Net GST received 370 370 370 370 370 Other cash received 4,354 3,516 3,539 3,566 3,573 Cash from the Official Public Account 221 - 78 83 19 Total cash received 11,146 10,005 10,072 10,118 10,074 Cash used Employees 6,862 6,195 6,022 6,480 6,575 Suppliers 3,271 3,204 3,285 3,233 3,093 Net GST paid 369 370 370 370 370 Cash to the Official Public Account - 168 - - - Total cash used 10,502 9,937 9,677 10,083 10,038 Net cash from (or used by) operating activities 644 68 395 35 36 INVESTING ACTIVITIES Cash used Purchase of property, plant and equipment 1,741 183 1,076 99 101 Total cash used 1,741 183 1,076 99 101 Net cash from (or used by) investing activities (1,741) (183) (1,076) (99) (101) FINANCING ACTIVITIES Cash received Capital budget - Bill 1 (DCB) 1,097 115 681 64 65 Total cash received 1,097 115 681 64 65 Net cash from (or used by) 1,097 115 681 64 65 financing activities Net increase (or decrease) in cash - - - - - held Cash and cash equivalents at the beginning of the reporting period 30 30 30 30 30 Cash and cash equivalents at the end of the reporting period 30 30 30 30 30

Table 3.2.5: Capital budget statement Estimated Budget Forward Forward Forward actual estimate estimate estimate estimate 2012-13 2013-14 2014-15 2015-16 2016-17 $'000 $'000 $'000 $'000 $'000 CAPITAL APPROPRIATIONS Capital budget - Bill 1 (DCB) 1,097 115 681 64 65 Total capital appropriations 1,097 115 681 64 65 Total new capital appropriations represented by: Purchase of non-financial assets 1,097 115 681 64 65 Total items 1,097 115 681 64 65 PURCHASE OF NON-FINANCIAL ASSETS Funded by capital appropriation - DCB1 1,097 115 681 64 65 Funded internally from departmental resources 644 68 395 35 35 Total acquisitions of non- financial assets 1,741 183 1,076 99 100 RECONCILIATION OF CASH USED TO ACQUIRE ASSETS TO ASSET MOVEMENT TABLE Total purchases 1,741 183 1,076 99 101 Total cash used to acquire assets 1,741 183 1,076 99 101

1 Does not include annual finance lease costs. Includes purchase from current and previous years' appropriation (Departmental Capital Budget).

Table 3.2.6: Statement of Departmental Asset Movements (2013-14) Building Other property, Intangible Total s plant & s equipment $'000 $'000 $'000 $'000 As at 1 July 2013 Gross book value 1,157 999 3,559 5,715 Accumulated depreciation/amortisation and impairment 167 451 3,097 3,715 Opening net book balance 990 548 462 2,000 CAPITAL ASSET ADDITIONS Estimated expenditure on new or replacement assets By purchase – appropriation ordinary annual services - 11 104 115 By purchase – internal departmental resources - 6 62 68 Sub-total - 17 166 183 Other movements Depreciation/amortisation expense 100 192 354 646 Disposals1 - - - - Other - - - - as at 30 June 2014 Gross book value 1,157 1,016 3,725 5,898 Accumulated depreciation/amortisation and impairment 267 643 3,451 4,361 Closing net book balance 890 373 274 1,537

1 Proceeds may be returned to the Official Public Account.

Table 3.2.7: Schedule of Budgeted Income and Expenses Administered on Behalf of Government (for the period ended 30 June) Estimate Budget Forward Forward Forward d estimate estimate estimate estimate actual 2013-14 2014-15 2015-16 2016-17 2012-13 $'000 $'000 $'000 $'000 $'000 INCOME ADMINISTERED ON BEHALF OF GOVERNMENT Revenue Non-taxation Other sources of non-taxation 1,222,59 revenues 1,084,788 1,145,304 5 1,300,702 1,387,858 1,222,59 Total non-taxation 1,084,788 1,145,304 5 1,300,702 1,387,858 Total revenues administered 1,222,59 on behalf of Government 1,084,788 1,145,304 5 1,300,702 1,387,858 Total income administered on 1,222,59 behalf of Government 1,084,788 1,145,304 5 1,300,702 1,387,858 EXPENSES ADMINISTERED ON BEHALF OF GOVERNMENT 1,203,00 Suppliers 1,077,314 1,127,315 9 1,280,081 1,370,351 Depreciation and amortisation 115 99 - - - Total expenses administered 1,203,00 on behalf of Government 1,077,429 1,127,414 9 1,280,081 1,370,351

Table 3.2.8: Schedule of Budgeted Assets and Liabilities Administered on Behalf of Government (as at 30 June) Estimated Budget Forward Forward Forward actual estimate estimate estimate estimate

2012-13 2013-14 2014-15 2015-16 2016-17 $'000 $'000 $'000 $'000 $'000 ASSETS ADMINISTERED ON BEHALF OF GOVERNMENT Financial assets Cash and cash equivalent 6,081 533 547 561 575 Receivables 17,609 18,367 19,203 20,039 20,039 Investments 101,068 117,030 128,346 140,697 149,934 Total financial assets 124,758 135,930 148,096 161,297 170,548 Non-financial assets Property, plant and equipment 404 404 404 404 404 Intangibles 946 847 847 847 847 Inventories 60,173 60,173 60,173 60,173 60,173 Other 76,068 76,068 76,068 76,068 76,068 Total non-financial assets 137,591 137,492 137,492 137,492 137,492 Total assets administered on behalf of Government 262,349 273,422 285,588 298,789 308,040 LIABILITIES ADMINISTERED ON BEHALF OF GOVERNMENT Interest bearing liabilities Payables Suppliers 68,134 75,703 84,061 92,419 92,419 Total payables 68,134 75,703 84,061 92,419 92,419 Total liabilities administered on behalf of Government 68,134 75,703 84,061 92,419 92,419

Table 3.2.9: Schedule of Budgeted Administered Cash Flows (for the period ended 30 June) Estimate Budget Forward Forward Forward d estimate estimate estimate estimate actual 2013-14 2014-15 2015-16 2016-17 2012-13 $'000 $'000 $'000 $'000 $'000 OPERATING ACTIVITIES Cash received Net GST received 108,833 117,694 127,575 127,575 127,575 Other 410,440 429,265 458,474 488,798 519,962 Total cash received 519,273 546,959 586,049 616,373 647,537 Cash used 1,194,65 Suppliers 1,064,730 1,119,746 1 1,271,723 1,361,993 Grant payments - - - - - Net GST paid 109,474 118,452 128,411 128,411 128,411 Other - - - - - 1,323,06 Total cash used 1,174,204 1,238,198 2 1,400,134 1,490,404 Net cash from (or used by) investing activities (654,931) (691,239) (737,013) (783,761) (842,867) INVESTING ACTIVITIES Cash used Purchase of Investments 12,733 15,962 11,316 12,351 9,237 Total cash used 12,733 15,962 11,316 12,351 9,237 Net cash from (or used by) investing activities (12,733) (15,962) (11,316) (12,351) (9,237) Net increase (or decrease) in cash held (667,664) (707,201) (748,329) (796,112) (852,104) Cash at beginning of reporting period 5,340 6,081 533 547 561 Cash from Official Public Account for: - special accounts 674,348 716,039 764,121 811,904 867,896 - appropriations 8,358 7,544 - - - Cash to Official Public Account for: - Appropriations 14,301 21,930 15,778 15,778 15,778 - Special Accounts - - - - - Cash at end of reporting period 6,081 533 547 561 575